• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒药理学:孕妇和新生儿的特殊问题。

Antiretroviral pharmacology: special issues regarding pregnant women and neonates.

机构信息

Division of Neonatology, Department of Pediatrics, Boston University School of Medicine, 771 Albany Street - Dowling 4111, Boston, MA 02118, USA.

出版信息

Clin Perinatol. 2010 Dec;37(4):907-27, xi. doi: 10.1016/j.clp.2010.08.006.

DOI:10.1016/j.clp.2010.08.006
PMID:21078458
Abstract

Antiretrovirals may be used in pregnant women infected with the HIV and their newborns both for treatment of maternal HIV disease and for prevention of mother-to-child transmission of HIV. More than 25 antiretroviral agents in 5 classes have been approved, with new drugs and classes in development. This article reviews current knowledge of the pharmacology of these drugs during pregnancy and in the newborn period, highlighting those pharmacologic issues critical to the safe and effective use of antiretrovirals in these populations.

摘要

抗逆转录病毒药物可用于治疗感染 HIV 的孕妇及其新生儿,以治疗母体 HIV 疾病并预防 HIV 母婴传播。目前已有超过 25 种 5 类抗逆转录病毒药物获得批准,还有新的药物和类别正在研发中。本文综述了这些药物在妊娠期间和新生儿期的药理学知识,重点介绍了对这些人群安全有效使用抗逆转录病毒药物至关重要的药理学问题。

相似文献

1
Antiretroviral pharmacology: special issues regarding pregnant women and neonates.抗逆转录病毒药理学:孕妇和新生儿的特殊问题。
Clin Perinatol. 2010 Dec;37(4):907-27, xi. doi: 10.1016/j.clp.2010.08.006.
2
Antiretroviral use during pregnancy for treatment or prophylaxis.妊娠期抗逆转录病毒治疗或预防应用。
Expert Opin Pharmacother. 2011 Aug;12(12):1875-85. doi: 10.1517/14656566.2011.584062. Epub 2011 May 3.
3
International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.资源有限环境下用于治疗感染艾滋病毒妇女及预防母婴艾滋病毒传播的抗逆转录病毒药物国际建议:2006年更新版
Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S42-55. doi: 10.1016/j.ajog.2007.03.001.
4
Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.拉丁美洲和加勒比地区站点对感染人类免疫缺陷病毒的孕妇的管理。
Obstet Gynecol. 2007 Jun;109(6):1358-67. doi: 10.1097/01.AOG.0000265211.76196.ac.
5
HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.美国预防母婴传播的艾滋病毒检测与预防措施。
Pediatrics. 2008 Nov;122(5):1127-34. doi: 10.1542/peds.2008-2175.
6
Human immunodeficiency virus infection and pregnancy.人类免疫缺陷病毒感染与妊娠
Clin Dermatol. 2006 Nov-Dec;24(6):536-42. doi: 10.1016/j.clindermatol.2006.05.003.
7
HIV drug resistance and mother-to-child transmission of HIV.HIV 耐药性和 HIV 的母婴传播。
Clin Perinatol. 2010 Dec;37(4):825-42, x. doi: 10.1016/j.clp.2010.08.009.
8
Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.美国孕妇人类免疫缺陷病毒筛查、预防及治疗建议
Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S26-32. doi: 10.1016/j.ajog.2007.03.087.
9
Resistance to antiretrovirals in HIV-infected pregnant women.HIV感染孕妇对抗逆转录病毒药物的耐药性。
J Clin Virol. 2009 May;45(1):39-42. doi: 10.1016/j.jcv.2009.02.009. Epub 2009 Mar 28.
10
Prevention of mother-to-child transmission of HIV: antiretroviral strategies.预防母婴传播艾滋病毒:抗逆转录病毒策略。
Clin Perinatol. 2010 Dec;37(4):765-76, viii. doi: 10.1016/j.clp.2010.08.007.

引用本文的文献

1
The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub-Saharan Africa: state of the science and research priorities.评估和解决撒哈拉以南非洲地区孕妇和产后使用 PrEP 时的心理健康障碍的重要性:科学现状和研究重点。
J Int AIDS Soc. 2022 Oct;25(10):e26026. doi: 10.1002/jia2.26026.
2
Atovaquone-proguanil exposure in pregnancy and risk for adverse fetal and infant outcomes: A retrospective analysis.孕期阿托伐醌-氯胍暴露与胎儿及婴儿不良结局风险:一项回顾性分析。
Travel Med Infect Dis. 2019 Nov-Dec;32:101519. doi: 10.1016/j.tmaid.2019.101519. Epub 2019 Nov 17.
3
Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa.
建立模型评估在南非为孕妇和哺乳期妇女提供暴露前预防措施的潜在影响。
AIDS. 2019 Jul 1;33(8):1391-1395. doi: 10.1097/QAD.0000000000002221.
4
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.1999 - 2015年美国依法韦仑作为一线抗逆转录病毒疗法的使用模式
Antivir Ther. 2018;23(4):363-372. doi: 10.3851/IMP3223.
5
Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.孕妇药物剂量:应用生理基于药代动力学模型和模拟的挑战与机遇。
CPT Pharmacometrics Syst Pharmacol. 2018 Feb;7(2):103-110. doi: 10.1002/psp4.12274. Epub 2018 Jan 31.
6
Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier.在撒哈拉以南非洲向孕妇和哺乳期妇女提供暴露前预防措施:实施科学前沿。
AIDS. 2017 Oct 23;31(16):2193-2197. doi: 10.1097/QAD.0000000000001604.
7
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.依曲韦林在感染HIV的孕妇中的药代动力学。
Front Pharmacol. 2016 Aug 4;7:239. doi: 10.3389/fphar.2016.00239. eCollection 2016.
8
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.孕期感染HIV女性中达芦那韦每日一次与每日两次给药的药代动力学
J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):33-41. doi: 10.1097/QAI.0000000000000668.
9
Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.抗逆转录病毒疗法、妊娠与出生缺陷:关于最新数据的讨论
HIV AIDS (Auckl). 2013 Aug 1;5:181-9. doi: 10.2147/HIV.S15542. eCollection 2013.
10
Raltegravir in vitro effect on bilirubin binding.拉替拉韦体外对胆红素结合的影响。
Pediatr Infect Dis J. 2013 Sep;32(9):978-80. doi: 10.1097/INF.0b013e31829044a8.